PATH | VRL
Menu

Find resources

Total results with these characteristics: 67

Disease: Respiratory syncytial virus (RSV)

Page 4 of 4
Vaccination Against Respiratory Syncytial Virus in Pregnancy: A Suitable Tool to Combat Global Infant Morbidity and Mortality?

This article, published in The Lancet Infectious Diseases, describes the epidemiological and immunological background of respiratory syncytial virus (RSV) infection and the pipeline of RSV vaccines in development. It discusses the potential for …

Author: Saso A, Kampmann B

Publication date: 2016

Vaccine-Enhanced Respiratory Syncytial Virus Disease in Cotton Rats Following Immunization with Lot 100 or a Newly Prepared Reference Vaccine

A formalin-inactivated respiratory syncytial virus vaccine was used to immunize infants in the mid-1960s; when these children later were naturally infected by the virus they developed markedly accentuated disease, and two died. For the present work, …

Author: Prince GA, Curtis SJ, Yim KC, Porter DD

Publication date: 2001

Vaccines Against Respiratory Syncytial Virus: The Time Has Finally Come

This article, published in Vaccine, provides an overview of respiratory syncytial virus disease and the efforts to develop a vaccine. It details different vaccine development approaches and outlines the goals of vaccination in different target …

Author: Graham BS

Publication date: 2016

Vaccines for the Future

Published from 2007 to 2015, this quarterly e-newsletter provided updates on PATH’s efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against the leading causes of childhood deaths in developing-world …

Author: PATH

Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

The authors of this article, published in the Journal of Virology, discuss the contributions of viral versus various host factors to respiratory syncytial virus (RSV) pathogenesis. The authors conclude that a better understanding of the viral and …

Author: Collins PL, Graham BS

Publication date: 2008

WHO Consultation on Respiratory Syncytial Virus Vaccine Development Report From a World Health Organization Meeting Held on 23–24 March 2015

This article, published in Vaccine, summarizes a World Health Organization-convened respiratory syncytial virus (RSV) vaccine consultation held on March 23 and 24, 2015 in Geneva, Switzerland, which brought together experts from around the world to …

Author: Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, the WHO RSV Vaccine Consultation Expert Group

Publication date: 2015

WHO Preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines

This report provides guidance on vaccine development strategies and targets for RSV vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target population, …

Author: World Health Organization

Publication date: 2017

Page 4 of 4